Literature DB >> 10848584

A GG nucleotide sequence of the 3' untranslated region of amyloid precursor protein mRNA plays a key role in the regulation of translation and the binding of proteins.

E G Mbella1, S Bertrand, G Huez, J N Octave.   

Abstract

The alternative polyadenylation of the mRNA encoding the amyloid precursor protein (APP) involved in Alzheimer's disease generates two molecules, with the first of these containing 258 additional nucleotides in the 3' untranslated region (3'UTR). We have previously shown that these 258 nucleotides increase the translation of APP mRNA injected in Xenopus oocytes (5). Here, we demonstrate that this mechanism occurs in CHO cells as well. We also present evidence that the 3'UTR containing 8 nucleotides more than the short 3'UTR allows the recovery of an efficiency of translation similar to that of the long 3'UTR. Moreover, the two guanine residues located at the 3' ends of these 8 nucleotides play a key role in the translational control. Using gel retardation mobility shift assay, we show that proteins from Xenopus oocytes, CHO cells, and human brain specifically bind to the short 3'UTR but not to the long one. The two guanine residues involved in the translational control inhibit this specific binding by 65%. These results indicate that there is a correlation between the binding of proteins to the 3'UTR of APP mRNA and the efficiency of mRNA translation, and that a GG motif controls both binding of proteins and translation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848584      PMCID: PMC85851          DOI: 10.1128/MCB.20.13.4572-4579.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences.

Authors:  J T Rogers; L M Leiter; J McPhee; C M Cahill; S S Zhan; H Potter; L N Nilsson
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

2.  Gene dosage of the amyloid beta precursor protein in Alzheimer's disease.

Authors:  M B Podlisny; G Lee; D J Selkoe
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

3.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Authors:  J Kang; H G Lemaire; A Unterbeck; J M Salbaum; C L Masters; K H Grzeschik; G Multhaup; K Beyreuther; B Müller-Hill
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

Review 4.  Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation.

Authors:  A M Thomson; J T Rogers; P J Leedman
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

5.  Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay.

Authors:  N Xu; C Y Chen; A B Shyu
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

6.  Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.

Authors:  W S Lai; E Carballo; J R Strum; E A Kennington; R S Phillips; P J Blackshear
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

7.  TGF-beta(1), regulation of alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization.

Authors:  F M Amara; A Junaid; R R Clough; B Liang
Journal:  Brain Res Mol Brain Res       Date:  1999-07-23

8.  The 3' untranslated region of the human interferon-beta mRNA has an inhibitory effect on translation.

Authors:  V Kruys; M Wathelet; P Poupart; R Contreras; W Fiers; J Content; G Huez
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA.

Authors:  L E Rajagopalan; C J Westmark; J A Jarzembowski; J S Malter
Journal:  Nucleic Acids Res       Date:  1998-07-15       Impact factor: 16.971

View more
  8 in total

1.  MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed.

Authors:  Justin M Long; Debomoy K Lahiri
Journal:  Biochem Biophys Res Commun       Date:  2010-12-21       Impact factor: 3.575

2.  MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients.

Authors:  Justin M Long; Balmiki Ray; Debomoy K Lahiri
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

Review 3.  Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders.

Authors:  Justin M Long; Debomoy K Lahiri
Journal:  Exp Neurol       Date:  2012-01-05       Impact factor: 5.330

4.  Translational silencing of ceruloplasmin requires the essential elements of mRNA circularization: poly(A) tail, poly(A)-binding protein, and eukaryotic translation initiation factor 4G.

Authors:  B Mazumder; V Seshadri; H Imataka; N Sonenberg; P L Fox
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

5.  Post-transcriptional regulation of amyloid precursor protein by microRNAs and RNA binding proteins.

Authors:  Francesca Ruberti; Christian Barbato; Carlo Cogoni
Journal:  Commun Integr Biol       Date:  2010-11-01

Review 6.  Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.

Authors:  Catherine M Cahill; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  Biochim Biophys Acta       Date:  2008-12-29

7.  Alzheimer's brains show inter-related changes in RNA and lipid metabolism.

Authors:  Shahar Barbash; Benjamin P Garfinkel; Rotem Maoz; Alon Simchovitz; Bettina Nadorp; Alessandro Guffanti; Estelle R Bennett; Courtney Nadeau; Andreas Türk; Lukas Paul; Torsten Reda; Yan Li; Aron S Buchman; David S Greenberg; Alexander Seitz; David A Bennett; Patrick Giavalisco; Hermona Soreq
Journal:  Neurobiol Dis       Date:  2017-06-17       Impact factor: 5.996

8.  Alternative cleavage and polyadenylation of genes associated with protein turnover and mitochondrial function are deregulated in Parkinson's, Alzheimer's and ALS disease.

Authors:  Radhika Patel; Cillian Brophy; Mark Hickling; Jonathan Neve; André Furger
Journal:  BMC Med Genomics       Date:  2019-05-09       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.